换一批
换一批Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib.
第一作者：
Zelong,Yang
第一单位：
Key Laboratory of Hepatobiliary and Pancreatic Surgery, Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Shapingba, Chongqing 400038, P.R. China.
作者：
主题词
动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);癌, 肝细胞(Carcinoma, Hepatocellular);细胞运动(Cell Movement);细胞增殖(Cell Proliferation);环戊烷类(Cyclopentanes);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male);小鼠(Mice);中年人(Middle Aged);肿瘤蛋白质类(Neoplasm Proteins);嘧啶类(Pyrimidines);泛素激活酶类(Ubiquitin-Activating Enzymes);泛素类(Ubiquitins);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.3892/or.2019.7098
PMID
31002342
发布时间
2025-01-17
- 浏览11
Oncology reports
3257-3269页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
